Delgocitinib 2% Cream Therapeutic Cheat Sheet
Delgocitinib is a topical pan-Janus kinase (JAK) inhibitor that represents a novel non-steroidal treatment mechanism for chronic hand dermatitis. As a pan-JAK inhibitor, delgocitinib blocks all four members of the JAK family (JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2)), thus simultaneously modulating the many cytokine pathways that drive chronic inflammatory skin disorders. Delgocitinib was in …
Delgocitinib is a topical pan-Janus kinase (JAK) inhibitor that represents a novel non-steroidal treatment mechanism for chronic hand dermatitis. As a pan-JAK inhibitor, delgocitinib blocks all four members of the JAK family (JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2)), thus simultaneously modulating the many cytokine pathways that drive chronic inflammatory skin disorders. Delgocitinib was in … Continue reading "Delgocitinib 2% Cream Therapeutic Cheat Sheet"
Bemotrizinol’s recent FDA approval – the first new approval of a UV filter in more than 20 years -- made headlines in several media outlets, including NPR. The broad-spectrum, chemical sunscreen ingredient is a welcome addition to the U.S. market, according to dermatologists, who have been advocating for its approval for decades. The U.S. lags behind other countries in the number of approved s … 
Summer means news articles on sun protection and the dangers of tanning, and for the first time in more than 20 years, the news includes FDA approval of a sunscreen ingredient. As detailed by NPR, newly approved bemotrizinol protects against both UVA and UVB rays, and is photo stable, offering longer protection than other U.S. sunscreens. Even the Environmental Working Group (EWG) is excited about …